Differences in pharmacological migraine treatment across different levels of clinical headache care – a cross-sectional study
Compared to previous studies, the overall prescription of acute and prophylactic therapies in primary and secondary care facilities has improved. Further progress is needed in expanding the range of triptans and prophylactic treatments tested before referring patients to specialized centers. However, given the selected study population, the findings may not be fully applicable to all patients treated in primary/secondary care, especially those already receiving adequate care without being referred to specialized settings.
Authors
- Ulrich Martin (ORCID: https://orcid.org/0000-0002-1237-0426)
- Ja Bin Hong (ORCID: https://orcid.org/0009-0002-1541-0291)
- Bianca Raffaelli (ORCID: https://orcid.org/0000-0001-9758-1494)
- Uwe Reuter (ORCID: https://orcid.org/0000-0002-8527-0725)
- Mira Pauline Fitzek (ORCID: https://orcid.org/0000-0003-0299-4830)
- Kristin Sophie Lange (ORCID: https://orcid.org/0000-0002-8056-8514)
- Lucas Hendrik Overeem (ORCID: https://orcid.org/0000-0003-2057-7184)
- Carolin Luisa Hoehne
- Yones Salim
Institutions
- Universitätsmedizin Greifswald (DE)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- The Journal of Headache and Pain
- Published
- 2025-04-14
- DOI
- https://doi.org/10.1186/s10194-025-02027-x
- Citations
- 9
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 13.24